LOPERAMIDE REF 2 mg, hard capsule 12 capsules
Active ingredients: Loperamide hydrochloride, Loperamide
Commercialized according to BDPM
Hard capsule12 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOPERAMIDE REF 2 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 12 gélule(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Sept 2022
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63088070CIP72788334CIP133400927883347Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LOPÉRAMIDEgélule | 2 mg · une gélule | SA |
| LOPÉRAMIDEgélule | 1,86 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.